215 related articles for article (PubMed ID: 23060003)
1. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
Gupta A; Yu X; Case T; Paul M; Shen MM; Kaestner KH; Matusik RJ
Prostate; 2013 May; 73(6):582-9. PubMed ID: 23060003
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
[TBL] [Abstract][Full Text] [Related]
3. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.
Qi J; Nakayama K; Cardiff RD; Borowsky AD; Kaul K; Williams R; Krajewski S; Mercola D; Carpenter PM; Bowtell D; Ronai ZA
Cancer Cell; 2010 Jul; 18(1):23-38. PubMed ID: 20609350
[TBL] [Abstract][Full Text] [Related]
4. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
5. RNA interference of achaete-scute homolog 1 in mouse prostate neuroendocrine cells reveals its gene targets and DNA binding sites.
Hu Y; Wang T; Stormo GD; Gordon JI
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5559-64. PubMed ID: 15060276
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.
Chiaverotti T; Couto SS; Donjacour A; Mao JH; Nagase H; Cardiff RD; Cunha GR; Balmain A
Am J Pathol; 2008 Jan; 172(1):236-46. PubMed ID: 18156212
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.
Liu Q; Pang J; Wang LA; Huang Z; Xu J; Yang X; Xie Q; Huang Y; Tang T; Tong D; Liu G; Wang L; Zhang D; Ma Q; Xiao H; Lan W; Qin J; Jiang J
J Pathol; 2021 Jan; 253(1):106-118. PubMed ID: 33009820
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers.
Mauri G; Jachetti E; Comuzzi B; Dugo M; Arioli I; Miotti S; Sangaletti S; Di Carlo E; Tripodo C; Colombo MP
Oncotarget; 2016 Jan; 7(4):3905-20. PubMed ID: 26700622
[TBL] [Abstract][Full Text] [Related]
9. Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.
Patel SJ; Molinolo AA; Gutkind S; Crawford NP
PLoS One; 2013; 8(4):e61848. PubMed ID: 23620793
[TBL] [Abstract][Full Text] [Related]
10. Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β.
Jachetti E; Rigoni A; Bongiovanni L; Arioli I; Botti L; Parenza M; Cancila V; Chiodoni C; Festinese F; Bellone M; Tardanico R; Tripodo C; Colombo MP
Mol Cancer Ther; 2017 Feb; 16(2):365-375. PubMed ID: 27980106
[TBL] [Abstract][Full Text] [Related]
11. FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.
Park JW; Lee JK; Witte ON; Huang J
Mod Pathol; 2017 Sep; 30(9):1262-1272. PubMed ID: 28621319
[TBL] [Abstract][Full Text] [Related]
12. Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.
Huss WJ; Gray DR; Tavakoli K; Marmillion ME; Durham LE; Johnson MA; Greenberg NM; Smith GJ
Neoplasia; 2007 Nov; 9(11):938-50. PubMed ID: 18030362
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Kaur H; Samarska I; Lu J; Faisal F; Maughan BL; Murali S; Asrani K; Alshalalfa M; Antonarakis ES; Epstein JI; Joshu CE; Schaeffer EM; Mosquera JM; Lotan TL
Prostate; 2020 Sep; 80(12):1012-1023. PubMed ID: 32649013
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice.
Hu Y; Ippolito JE; Garabedian EM; Humphrey PA; Gordon JI
J Biol Chem; 2002 Nov; 277(46):44462-74. PubMed ID: 12228243
[TBL] [Abstract][Full Text] [Related]
15. The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.
Qi J; Pellecchia M; Ronai ZA
Oncotarget; 2010 Sep; 1(5):379-85. PubMed ID: 21037926
[TBL] [Abstract][Full Text] [Related]
16. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
17. Foxa2 activates the transcription of androgen receptor target genes in castrate resistant prostatic tumors.
Connelly ZM; Yang S; Chen F; Yeh Y; Khater N; Jin R; Matusik R; Yu X
Am J Clin Exp Urol; 2018; 6(5):172-181. PubMed ID: 30510969
[TBL] [Abstract][Full Text] [Related]
18. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
[TBL] [Abstract][Full Text] [Related]
19. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.
Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J
Mol Cell Biol; 2002 Mar; 22(5):1495-503. PubMed ID: 11839815
[TBL] [Abstract][Full Text] [Related]
20. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL
Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]